May 04, 2026 : Sudarshan Pharma Industries has announced that its board of directors will meet on April 30 to consider and approve the company’s audited financial results for FY26.

Author: Aadarsh Patel | EQMint

The meeting will include approval of both standalone and consolidated financial results for the quarter and financial year ended March 31, 2026.

The company shared the update through a regulatory filing submitted to BSE. The stock is listed under the trading symbol “SUDARSHAN”.

Sudarshan Pharma also confirmed that the trading window for the company will remain closed until 48 hours after the financial results are officially declared.

Such trading window restrictions are typically imposed to prevent insider trading ahead of major financial announcements.

Investors will now closely watch the upcoming earnings announcement for signals around revenue growth, margins and business outlook for FY27.

The board meeting notification was signed by Company Secretary and Compliance Officer Nirav Shah.

For more such information visit EQMint

Join our Whatsapp channel for timely updates: Whatsapp

Disclaimer:  This article is not an investment advice and is for educational purpose only